Acute Crit Care.  2020 Nov;35(4):237-241. 10.4266/acc.2020.00941.

Damage control strategy in bleeding trauma patients

• Kim M
• Cho H

• KMID: 2510541
• DOI: http://doi.org/10.4266/acc.2020.00941

Abstract

Hemorrhagic shock is a main cause of death in severe trauma patients. Bleeding trauma patients have coagulopathy on admission, which may even be aggravated by incorrectly directed resuscitation. The damage control strategy is a very urgent and essential aspect of management considering the acute coagulopathy of trauma and the physiological status of bleeding trauma patients. This strategy has gained popularity over the past several years. Patients in extremis cannot withstand prolonged definitive surgical repair. Therefore, an abbreviated operation, referred to as damage control surgery (DCS), is needed. In addition to DCS, the likelihood of survival should be maximized for patients in extremis by providing appropriate critical care, including permissive hypotension, hemostatic resuscitation, minimization of crystalloid use, early use of tranexamic acid, and avoidance of hypothermia and hypocalcemia. This review presents an overview of the evolving strategy of damage control in bleeding trauma patients.

Keyword

blood transfusion; critical care; hemorrhage; injury; resuscitation

Figure

• 

  Figure 1. Four main components of damage control resuscitation.

Reference

1. Jung K, Kim I, Park SK, Cho H, Park CY, Yun JH, et al. Preventable trauma death rate after establishing a national trauma system in Korea. J Korean Med Sci. 2019; 34:e65.

2. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, et al. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995; 38:185–93.

3. Stone HH, Strom PR, Mullins RJ. Management of the major coagulopathy with onset during laparotomy. Ann Surg. 1983; 197:532–5.

4. Rotondo MF, Schwab CW, McGonigal MD, Phillips GR 3rd, Fruchterman TM, Kauder DR, et al. ‘Damage control’: an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma. 1993; 35:375–83.

5. Sutton E, Bochicchio GV, Bochicchio K, Rodriguez ED, Henry S, Joshi M, et al. Long term impact of damage control surgery: a preliminary prospective study. J Trauma. 2006; 61:831–6.

6. Johnson JW, Gracias VH, Schwab CW, Reilly PM, Kauder DR, Shapiro MB, et al. Evolution in damage control for exsanguinating penetrating abdominal injury. J Trauma. 2001; 51:261–71.

7. Khan S, Davenport R, Raza I, Glasgow S, De’Ath HD, Johansson PI, et al. Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage. Intensive Care Med. 2015; 41:239–47.

8. Ball CG. Damage control resuscitation: history, theory and technique. Can J Surg. 2014; 57:55–60.

9. Midwinter MJ. Damage control surgery in the era of damage control resuscitation. J R Army Med Corps. 2009; 155:323–6.

10. Parr MJ, Alabdi T. Damage control surgery and intensive care. Injury. 2004; 35:713–22.

11. Mizobata Y. Damage control resuscitation: a practical approach for severely hemorrhagic patients and its effects on trauma surgery. J Intensive Care. 2017; 5:4.

12. Spahn DR, Bouillon B, Cerny V, Duranteau J, Filipescu D, Hunt BJ, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care. 2019; 23:98.

13. American College of Surgeons. Advanced trauma life support program for doctors. 7th ed. Chicago: American College of Surgeons Committee on Trauma;2004.

14. American College of Surgeons. ATLS advanced trauma life support. 10th ed. Chicago: American College of Surgeons;2018.

15. Balogh Z, McKinley BA, Cocanour CS, Kozar RA, Valdivia A, Sailors RM, et al. Supranormal trauma resuscitation causes more cases of abdominal compartment syndrome. Arch Surg. 2003; 138:637–43.

16. Duke MD, Guidry C, Guice J, Stuke L, Marr AB, Hunt JP, et al. Restrictive fluid resuscitation in combination with damage control resuscitation: time for adaptation. J Trauma Acute Care Surg. 2012; 73:674–8.

17. Duchesne JC, Guidry C, Hoffman JR, Park TS, Bock J, Lawson S, et al. Low-volume resuscitation for severe intraoperative hemorrhage: a step in the right direction. Am Surg. 2012; 78:936–41.

18. Schreiber MA, Meier EN, Tisherman SA, Kerby JD, Newgard CD, Brasel K, et al. A controlled resuscitation strategy is feasible and safe in hypotensive trauma patients: results of a prospective randomized pilot trial. J Trauma Acute Care Surg. 2015; 78:687–97.

19. Harada MY, Ko A, Barmparas G, Smith EJ, Patel BK, Dhillon NK, et al. 10-Year trend in crystalloid resuscitation: reduced volume and lower mortality. Int J Surg. 2017; 38:78–82.

20. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007; 63:805–13.

21. Savage SA, Zarzaur BL, Croce MA, Fabian TC. Time matters in 1: 1 resuscitations: concurrent administration of blood: plasma and risk of death. J Trauma Acute Care Surg. 2014; 77:833–8.

22. Shaz BH, Dente CJ, Nicholas J, MacLeod JB, Young AN, Easley K, et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion. 2010; 50:493–500.

23. Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008; 248:447–58.

24. Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015; 313:471–82.

25. Johnston TD, Chen Y, Reed RL 2nd. Functional equivalence of hypothermia to specific clotting factor deficiencies. J Trauma. 1994; 37:413–7.

26. Gubler KD, Gentilello LM, Hassantash SA, Maier RV. The impact of hypothermia on dilutional coagulopathy. J Trauma. 1994; 36:847–51.

27. CRASH-2 collaborators, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011; 377:1096–101.

28. Moore HB, Moore EE, Liras IN, Gonzalez E, Harvin JA, Holcomb JB, et al. Acute fibrinolysis shutdown after injury occurs frequently and increases mortality: a multicenter evaluation of 2,540 severely injured patients. J Am Coll Surg. 2016; 222:347–55.

29. Lier H, Böttiger BW, Hinkelbein J, Krep H, Bernhard M. Coagulation management in multiple trauma: a systematic review. Intensive Care Med. 2011; 37:572–82.

30. Perkins JG, Cap AP, Weiss BM, Reid TJ, Bolan CD. Massive transfusion and nonsurgical hemostatic agents. Crit Care Med. 2008; 36(7 Suppl):S325–39.

31. MacKay EJ, Stubna MD, Holena DN, Reilly PM, Seamon MJ, Smith BP, et al. Abnormal calcium levels during trauma resuscitation are associated with increased mortality, increased blood product use, and greater hospital resource consumption: a pilot investigation. Anesth Analg. 2017; 125:895–901.

32. Webster S, Todd S, Redhead J, Wright C. Ionised calcium levels in major trauma patients who received blood in the emergency department. Emerg Med J. 2016; 33:569–72.

33. Giancarelli A, Birrer KL, Alban RF, Hobbs BP, Liu-DeRyke X. Hypocalcemia in trauma patients receiving massive transfusion. J Surg Res. 2016; 202:182–7.

34. Schreiber MA. The beginning of the end for damage control surgery. Br J Surg. 2012; 99 Suppl 1:10–1.